Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Chubb
Merck
Cipla
UBS
Federal Trade Commission
Queensland Health
Moodys
Cantor Fitzgerald
Chinese Patent Office

Generated: December 11, 2017

DrugPatentWatch Database Preview

Piperazine citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for piperazine citrate and what is the scope of piperazine citrate patent protection?

Piperazine citrate
is the generic ingredient in five branded drugs marketed by Glaxosmithkline, Sanofi Aventis Us, Bluline, Alpharma Us Pharms, Lannett, Luitpold, Solvay, and Impax Labs, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for piperazine citrate.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
GlaxosmithklineANTEPARpiperazine citrateSYRUP;ORAL009102-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SolvayVERMIDOLpiperazine citrateSYRUP;ORAL080992-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettPIPERAZINE CITRATEpiperazine citrateSYRUP;ORAL080963-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BlulineMULTIFUGEpiperazine citrateSYRUP;ORAL009452-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LuitpoldPIPERAZINE CITRATEpiperazine citrateSYRUP;ORAL080671-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
GlaxosmithklineANTEPARpiperazine citrateTABLET;ORAL009102-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsBRYRELpiperazine citrateSYRUP;ORAL017796-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alpharma Us PharmsPIPERAZINE CITRATEpiperazine citrateSYRUP;ORAL080774-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax LabsPIPERAZINE CITRATEpiperazine citrateTABLET;ORAL080874-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Fish and Richardson
QuintilesIMS
Dow
Cerilliant
McKinsey
UBS
US Department of Justice
Cantor Fitzgerald
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot